Tiziana Life Sciences PLC Director/PDMR Shareholding (7450Z)

TIDMTILS

RNS Number : 7450Z

Tiziana Life Sciences PLC

14 January 2020

Tiziana Life Sciences plc

PDMR Dealing

New York/London, 14 January 2020 - Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), a biotechnology company focusing on the discovery and development of innovative therapeutics for inflammation and oncology indications, announces that on the 13 January 2020 it was informed that on that date, Panetta Partners Limited, an entity closely associated with Gabriele Cerrone, Executive Chairman, bought 28,500 Ordinary Shares at a price of 43 pence per Ordinary Share, as set out below.

The information set out below is provided in accordance with the requirements of Regulation 19(3) of the EU Market Abuse Regulation No 596/2014:

 
1.  Details of PDMR / person closely associated 
a)  Name                             Gabriele Cerrone/Panetta Partners 
                                      Limited 
2.  Reason for the notification: On market acquisition 
a)  Position / status                Executive Chairman 
b)  Initial notification /amendment  Initial notification 
3.  Details of the issuer 
a)  Name                             Tiziana Life Sciences plc 
b)  LEI                              213800CED47HI8PIOB36 
4.  Details of the transaction(s): section to be repeated for 
     (i) each type of instrument; (ii) each type of transaction; 
     (iii) each date; and (iv) each place where transactions have 
     been conducted 
a)  Description of the financial     Ordinary Shares 
     instrument 
b)  Identification code of the       GB00BKWNZY55 
     Financial Instrument 
c)  Nature of the transaction        On market acquisition of ordinary 
                                      shares 
d)  Price(s) and volume(s)             Price: 43 pence; Volume: 28,500 
e)  Aggregated information 
     - Aggregated volume               N/A 
 
     - Price                           N/A 
f)  Date of the transaction          13 January 2020 
g)  Place of the transaction         AIM 
 

As a result of this transaction Mr Cerrone's interests in the underlying ordinary shares of the Company increases from 64,318,425 (47.066%) to 64,346,925 (47.087%). Mr Cerrone's interests in the ordinary shares of the Company are based on a holding of 63,680,404 ordinary shares held by Planwise Limited and voting rights in respect of 666,521 ordinary shares held by Panetta Partners Limited (as shares and via ADSs). Mr Cerrone is considered beneficially interested in the holdings of Panetta Partners Limited and Planwise Limited.

For more information go to http://www.tizianalifesciences.com

Contacts:

 
Tiziana Life Sciences plc 
 Gabriele Cerrone, Chairman and founder   [phone] 
Cairn Financial Advisers LLP (Nominated 
 adviser) 
 Liam Murray / Jo Turner                  [phone] 
Shore Capital (Broker) 
 Antonio Bossi / Fiona Conroy             [phone] 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHBGGDBUDBDGGS

(END) Dow Jones Newswires

January 14, 2020 06:00 ET (11:00 GMT)